University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
NCT Number: NCT04430426
This study seeks to examine the effects of a heterozygous mutation of the AGXT gene in a stone forming population on endogenous oxalate production. Participants will consume a controlled low-oxalate diet and provide blood and urine samples to measure the amount of oxalate in their bodies.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Birmingham, Alabama, 35233, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will consume a controlled low oxalate diet for five days.
Time frame: Baseline through Day 4
Urinary oxalate excretion from urine samples will be measured as mg/day
University of Alabama at Birmingham
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06330246
Calculi, Female Urogenital Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT06331546
Calculi, Female Urogenital Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT07071948
Calculi, Female Urogenital Diseases
Hangzhou, Zhejiang, China
View Trial DetailsNCT05081960
Calcium Oxalate Kidney Stones, Calcium Oxalate Urolithiasis
London, Ontario, Canada
View Trial Details